Stay updated on NRP104 Safety & Efficacy in Adult ADHD Clinical Trial
Sign up to get notified when there's something new on the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page.

Latest updates to the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page
- Check4 days agoChange DetectedThe site footer revision label changes from v3.8.0 to v3.8.1; the clinical trial record content remains unchanged.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed NRP104 ADHD trial, including its study design, eligibility criteria, locations, outcomes, and publications.SummaryDifference62%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The page continues to show a 403 error rather than the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the study record continues to show a 403 error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now presents a 403 Forbidden error, replacing the study record content with an access-denied message. The rest of the page layout remains visible, indicating an access restriction rather than an update to the study data.SummaryDifference17%

Stay in the know with updates to NRP104 Safety & Efficacy in Adult ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRP104 Safety & Efficacy in Adult ADHD Clinical Trial page.